The Japanese company Kubota Pharmaceutical Holdings has developed a prototype that might improve myopia. The smart glasses, named Kubota-Glasses are still in their testing stage but have so far shown promising results.
The Tokyo-based company specializes in identifying and developing therapeutics to treat ophthalmic diseases and is planning to release the glasses in Asia. A region where a high number of people struggle with myopia.
96.5% of 19-Year-Old Males are Suffering from Myopia in Seoul Alone
In fact, according to their website, “children in East Asia (including Japan, China, Hong Kong, Taiwan, South Korea, and Singapore) develop myopia at a high rate” with alarming rates in Asia alone.
The lenses of the Kubota-Glasses project an image onto the wearer’s retina to correct the refractive error that causes nearsightedness. The Japanese company states that the wearer requires to use the device between 60 to 90 minutes a day to correct myopia.
On the Right Track, but Kubota Needs More Transparency
On the other hand, Kubota has not provided additional details regarding how long does the device need to be worn daily to fully cure partial blindness or whether the effects are even permanent.
Myopia, or nearsightedness, is a common vision condition that causes blurred sight at a distance. It occurs when the shape of the eye causes light rays to bend incorrectly and tends to increases with age, especially during childhood and adolescence.
Some 2030 Myopia Facts
According to a report of the Joint World Health Organization – Brien Holden Vision Institute, myopia currently affects 2.56 billion people worldwide and is projected to affect as many as 3.4 billion people by 2030. If the treatment proposed by Kubota Pharmaceutical Holdings holds up to peer reviews and proves to be helpful, Kubota-Glasses might quill those numbers.
Follow TechTheLead on Google News to get the news first.
